eLife (Apr 2020)

High-phytate/low-calcium diet is a risk factor for crystal nephropathies, renal phosphate wasting, and bone loss

  • Ok-Hee Kim,
  • Carmen J Booth,
  • Han Seok Choi,
  • Jinwook Lee,
  • Jinku Kang,
  • June Hur,
  • Woo Jin Jung,
  • Yun-Shin Jung,
  • Hyung Jin Choi,
  • Hyeonjin Kim,
  • Joong-Hyuck Auh,
  • Jung-Wan Kim,
  • Ji-Young Cha,
  • Young Jae Lee,
  • Cheol Soon Lee,
  • Cheolsoo Choi,
  • Yun Jae Jung,
  • Jun-Young Yang,
  • Seung-Soon Im,
  • Dae Ho Lee,
  • Sun Wook Cho,
  • Young-Bum Kim,
  • Kyong Soo Park,
  • Young Joo Park,
  • Byung-Chul Oh

DOI
https://doi.org/10.7554/eLife.52709
Journal volume & issue
Vol. 9

Abstract

Read online

Phosphate overload contributes to mineral bone disorders that are associated with crystal nephropathies. Phytate, the major form of phosphorus in plant seeds, is known as an indigestible and of negligible nutritional value in humans. However, the mechanism and adverse effects of high-phytate intake on Ca2+ and phosphate absorption and homeostasis are unknown. Here, we show that excessive intake of phytate along with a low-Ca2+ diet fed to rats contributed to the development of crystal nephropathies, renal phosphate wasting, and bone loss through tubular dysfunction secondary to dysregulation of intestinal calcium and phosphate absorption. Moreover, Ca2+ supplementation alleviated the detrimental effects of excess dietary phytate on bone and kidney through excretion of undigested Ca2+-phytate, which prevented a vicious cycle of intestinal phosphate overload and renal phosphate wasting while improving intestinal Ca2+ bioavailability. Thus, we demonstrate that phytate is digestible without a high-Ca2+ diet and is a risk factor for phosphate overloading and for the development of crystal nephropathies and bone disease.

Keywords